InterCure Ltd. Share Price TEL AVIV STOCK EXCHANGE

INCR

IL0011063760

Healthcare Facilities & Services

News in other languages: InterCure Ltd.

02/01/20

Tilray, Inc. : première exportation de cannabis vers Israël

More news

Managers and Directors: InterCure Ltd.

Manager	Title	Age	Since
Alexander Rabinovitch CEO	Chief Executive Officer	55	23/12/2019
Amos Cohen DFI	Director of Finance/CFO	47	29/02/2020
Itai Kabiljo LAW	General Counsel	-	31/03/2022

Director	Title	Age	Since
Alexander Rabinovitch CHM	Chairman	55	12/02/2025
Alon Shmuel Granot BRD	Director/Board Member	65	31/10/2020
David Salton BRD	Director/Board Member	66	13/12/2014

More insiders

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Employees

Sector

Healthcare Facilities & Services

More about the company

Market Cap	179M 536M 156M 144M 134M 254M 17.05B 258M 1.73B 670M 8.36B 672M 658M 28.81B	P/E 2024	-4.01x	P/E 2025	-4.87x
Enterprise Value	315M 945M 276M 253M 236M 447M 30.03B 455M 3.05B 1.18B 14.73B 1.18B 1.16B 50.75B	EV / Sales 2024	1.69x	EV / Sales 2025	1.16x
Free-Float	75.95%	Yield 2024 *	-	Yield 2025	-

06-22	InterCure Ltd. announced that it expects to receive ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI
06-15	InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition	MT
06-14	InterCure Ltd. acquired 50% stake of Botanico Ltd.	CI
06-14	InterCure Ltd. completed the acquisition of 50% stake in Botanico Ltd.	CI
04-30	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-03	InterCure Receives Noncompliance Notice From Nasdaq	MT
03-03	InterCure receives Nasdaq notification regarding minimum bid requirement	RE
02-19	InterCure announces preliminary estimated 2025 revenue of NIS 265 million, positive adjusted EBITDA and cash of NIS 43 million	RE
12-18	InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court	RE
11-03	Cannasoul Analytics Ltd. announced that it expects to receive funding from InterCure Ltd.	CI
11-03	InterCure Ltd. Enters into A Collaboration Agreement with Cannasoul R&D Ltd	CI
08/10/25	InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
08/10/25	Intercure reports first half 2025 results with NIS 130 million in revenue and positive operating cash flow	RE

06-22	InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds	AQ
06-15	InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition	AQ
04-30	InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow	AQ
03-03	InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement	AQ
02-19	InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTERCURE LTD.	+0.22%	-0.51%	-	-	59.79M
VILLAGE FARMS INTERNATIONAL, INC.	-2.01%	+5.98%	+57.26%	+225.65%	223M
ORGANIGRAM GLOBAL INC.	+0.35%	+6.62%	-23.68%	-27.50%	144M
CANNARA BIOTECH INC.	+3.98%	+14.38%	+26.21%	+103.33%	127M
ASCEND WELLNESS HOLDINGS, INC.	0.00%	+4.44%	+38.24%	-24.19%	95.4M
JUSHI HOLDINGS INC.	+4.47%	-3.27%	+53.08%	-3.15%	92.84M
Average	+1.17%	+5.63%	+30.22%	+54.83%	136.49M
Weighted average by Cap.	+0.72%	+6.21%	+31.16%	+83.38%

	2024	2025
Net sales	239M 715M 209M 192M 179M 339M 22.74B 345M 2.31B 894M 11.15B 897M 877M 38.43B	270M 809M 236M 217M 202M 383M 25.72B 390M 2.61B 1.01B 12.62B 1.01B 992M 43.47B
Net income	-67.8M -203M -59.24M -54.4M -50.73M -96.17M -6.45B -97.79M -655M -254M -3.17B -255M -249M -10.91B	-35.71M -107M -31.2M -28.65M -26.72M -50.66M -3.4B -51.51M -345M -134M -1.67B -134M -131M -5.75B
Net Debt	133M 398M 116M 107M 99.34M 188M 12.64B 191M 1.28B 497M 6.2B 498M 488M 21.36B	136M 408M 119M 109M 102M 193M 12.98B 197M 1.32B 510M 6.37B 512M 501M 21.94B

InterCure Ltd. Share Price TEL AVIV STOCK EXCHANGE

Stocks

INCR

IL0011063760

Healthcare Facilities & Services

Valuation: InterCure Ltd.

Latest news : InterCure Ltd.

Press Releases: InterCure Ltd.

News in other languages: InterCure Ltd.

Quotes and Performance

Managers and Directors: InterCure Ltd.

Medical Farming

Financials

Company Profile